Rachel is primarily focused on building partnerships with organisations in the pharmaceutical sector; connecting partners with academics of interest, shaping and negotiating research collaborations and facilitating industry-led open innovation calls. Rachel also manages out-licensing of a portfolio of Faculty of Medicine technologies, primarily novel therapeutics.

Rachel joined Imperial in 2017 as part of the Management Trainee Graduate Scheme, and has been with the IPC FoM team since February 2020. Rachel holds a BSc in Biomedical Science from the University of Manchester.